Medicines Approved for Specific Cancers (M to Z)
Drugs Approved for Malignant Mesothelioma
Drugs Approved for Melanoma
Aldesleukin
Binimetinib
Cobimetinib
Dabrafenib
Dacarbazine
Encorafenib
Ipilimumab
Nivolumab
Peginterferon Alfa-2b
Pembrolizumab
Recombinant Interferon Alfa-2b
Talimogene Laherparepvec
Trametinib
Vemurafenib
Drugs Approved for Multicentric Castleman Disease
Siltuximab
Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
Bortezomib
Carfilzomib
Carmustine
Cyclophosphamide
Daratumumab
Doxorubicin
Elotuzumab
Ixazomib
Lenalidomide
Melphalan
Melphalan
Pamidronate
Panobinostat
Plerixafor
Pomalidomide
Thalidomide
Zoledronic Acid
Drugs Approved for Myeloproliferative Neoplasms
Arsenic Trioxide
Azacitidine
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin
Decitabine
Doxorubicin
Imatinib
Nilotinib
Ruxolitinib
Drugs Approved for Neuroblastoma
Cyclophosphamide
Dinutuximab
Doxorubicin
Vincristine
Drugs Approved for Non-Hodgkin’s Lymphoma
Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Bevacizumab
Carboplatin
Cisplatin
Cyclophosphamide
Doxorubicin
Gemcitabine
Melphalan
Niraparib
Olaparib
Paclitaxel
Rucaparib
Thiotepa
Topotecan
Drugs Approved for Pancreatic Cancer
Erlotinib
Everolimus
Fluorouracil
Gemcitabine
Irinotecan
Mitomycin C
Paclitaxel
Sunitinib
Drugs Approved for Penile Cancer
Bleomycin
Drugs Approved for Prostate Cancer
Abiraterone
Apalutamide
Bicalutamide
Cabazitaxel
Degarelix
Docetaxel
Enzalutamide
Flutamide
Goserelin
Leuprolide
Mitoxantrone
Nilutamide
Radium 223 Dichloride
Sipuleucel-T
Drugs Approved for Rectal Cancer
Bevacizumab
Capecitabine
Cetuximab
Fluorouracil
Ipilimumab
Irinotecan
Leucovorin
Nivolumab
Oxaliplatin
Panitumumab
Pembrolizumab
Ramucirumab
Regorafenib
Trifluridine and Tipiracil Hydrochloride
Ziv-Aflibercept
Drugs Approved for Retinoblastoma
Cyclophosphamide
Drugs Approved for Rhabdomyosarcoma
Dactinomycin
Vincristine
Drugs Approved for Melanoma
Aldesleukin
Cobimetinib
Dabrafenib
Dacarbazine
Ipilimumab
Nivolumab
Peginterferon Alfa-2b
Pembrolizumab
Recombinant Interferon Alfa-2b
Talimogene Laherparepvec
Trametinib
Vemurafenib
Drugs Approved for Merkel Cell Carcinoma
Avelumab
Pembrolizumab
Drugs Approved for Basal Cell Carcinoma
Fluorouracil
Imiquimod
Sonidegib
Vismodegib
Drugs Approved for Cutaneous Squamous Cell Carcinoma
Cemiplimab-rwlc
Drugs Approved for Soft Tissue Sarcoma
Dactinomycin
Doxorubicin
Eribulin
Imatinib
Olaratumab
Pazopanib
Trabectedin
Drugs Approved for Stomach Cancer
Docetaxel
Doxorubicin
Fluorouracil
Mitomycin C
Pembrolizumab
Ramucirumab
Trastuzumab
Trifluridine and Tipiracil Hydrochloride
Drugs Approved for Testicular Cancer
Bleomycin
Cisplatin
Dactinomycin
Etoposide
Ifosfamide
Vinblastine
Drugs Approved for Thyroid Cancer
Cabozantinib
Vandetanib
Dabrafenib
Doxorubicin
Lenvatinib
Sorafenib
Trametinib
Vandetanib
Drugs Approved for Vulvar Cancer
Bleomycin
Drugs Approved for Wilms Tumor
Dactinomycin
Dactinomycin
Doxorubicin
Vincristine